Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1542/pir.2021-005336 | DOI Listing |
J Comp Eff Res
February 2024
Acaster Lloyd Consulting Ltd, London, WC1X 8NL, UK.
This study estimated utility values for non-alcoholic steatohepatitis (NASH). Previous studies have assumed that health-related quality of life does not vary between the early stages of NASH. Discrete choice experiment (DCE) surveys estimated the value of avoiding fibrosis progression.
View Article and Find Full Text PDFPediatr Rev
September 2023
Division of Pediatric Cardiology, New York University Long Island, Mineola, NY.
Expert Opin Pharmacother
August 2022
Department of Psychiatry and Behavioral Neuroscience, St Louis University School of Medicine, St. Louis, Missouri, USA.
Introduction: Alzheimer's disease (AD) is a debilitating disease, with no cure. Recently, a monoclonal antibody (aducanumab) directed toward amyloid aggregates was approved as a disease-modifying treatment (DMT) for the disease. Other compounds (symptomatic or DMTs) are at different stages of clinical trial development.
View Article and Find Full Text PDFJ Vet Cardiol
April 2022
Department of Small Animal Clinical Sciences, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, 4474 TAMU, College Station, TX 77843-4474, USA.
Introduction: Screening to assess likelihood of preclinical dilated cardiomyopathy (PC-DCM) prior to advanced diagnostic tests in Doberman Pinschers (DP) is desirable.
Objective: To investigate the combined value of physical examination (PE), N-terminal pro B-type natriuretic peptide (NTproBNP) and cardiac troponin I (cTnI) for identifying PC-DCM in DP.
Animals, Materials And Methods: All dogs underwent: PE, echocardiogram, 3-min ECG and cardiac biomarker measurement.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!